![Matthias Will](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthias Will
Corporate Officer/Principal chez
AUTOLUS THERAPEUTICS PLC
Fortune : - $ au 30/06/2026
Profil
Matthias Will currently works at Autolus Therapeutics Plc, as Chief Development Officer from 2024.
Dr. Will also formerly worked at Dren Bio, Inc., as Chief Medical Officer, CytomX Therapeutics, Inc., as Head-Clinical Development, and CRISPR Therapeutics, Inc., as Vice President-Clinical Development Officer.
Dr. Will received his graduate degree from Hannover Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Matthias Will
| Sociétés | Poste | Début |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | 30/09/2024 |
Anciens postes connus de Matthias Will
| Sociétés | Poste | Fin |
|---|---|---|
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Corporate Officer/Principal | - |
| CYTOMX THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Directeur Technique/Scientifique/R&D | - |
Formation de Matthias Will
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Hannover Medical School
 Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Health Technology |
